| News > Unternehmensnachrichten > Affymax to Present at BIO CEO and ... - Ad-Hoc-News (Pressemitteilung) |
|
|
Affymax?s product candidate, Hematide?, is currently in Phase 3 clinical trials for the treatment of anemia associated with chronic renal failure. ... |